Your work will change lives. Including your own. 

The Impact You’ll Make

As a key member of Recursion's partnership-facing data science team, you will be at the forefront of reimagining drug discovery from first principles using Recursion’s massive data and compute capabilities. You will be the primary computational lead for a partnership portfolio of preclinical drug programs and will be responsible for collaboratively defining and executing a research strategy that identifies novel targets for immunology and inflammation (I&I) diseases, translationally validates disease contexts in hit-to-lead, and accelerates in vivo work in lead optimization.

You will integrate molecular and clinical data from public and partnered datasets with layers of Recursion platform data (phenomics, transcriptomics, proteomics, etc) to validate the link between target and disease biology and to propose programs in novel areas of immunology and inflammation. You will partner with machine learning and computational scientists from across the organization to develop, deploy, and scale novel approaches to: 1) translational validation in hit to lead, 2) mechanism-of-action identification/de-risking and in vivo validation in lead optimization, and 3) patient selection/indication expansion to match the medicines we are creating to the patients who need them.  

In this role, you will:

• Evaluate new data sources, develop and scale new analysis methods, and drive key program decisions with the ultimate goal of bringing life-changing therapies to patients at unprecedented speed
• Evaluate the molecular evidence for therapeutic hypotheses and accelerate drug program progression into the clinic
• Pilot novel methods for patient stratification and indication selection or expansion in immunology and inflammation
• Deliver biological insights on therapeutic candidates and disease biology from the analysis of high dimensional (phenomics, transcriptomics, proteomics, patient-derived) datasets that support clinical ...